• No results found

LBO Analysis Template

N/A
N/A
Protected

Academic year: 2021

Share "LBO Analysis Template"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

(1)

Investment Banking

Valuation, Leveraged Buyouts,

and Mergers & Acquisitions

LBO Analysis - Template

JOSHUA ROSENBAUM

JOSHUA PEARL

(2)

gvValueCo Corporation

Leveraged Buyout Analysis Financing Structure: Structure 1

($ in millions, fiscal year ending December 31) Operating Scenario: Base

Sources of Funds Uses of Funds Purchase Price Return Analysis

% of Total Multiple of EBITDA % of Total Offer Price per Share - Exit Year 2013

Amount Sources 9/30/2008 Cumulative Pricing Amount Uses Fully Diluted Shares - Entry Multiple - x

Revolving Credit Facility - - % - x - x NA Purchase ValueCo Equity - - % Equity Purchase Price - Exit Multiple - x

Term Loan A - - % - x - x NA Repay Existing Debt - - % Plus: Existing Net Debt - IRR NA Term Loan B - - % - x - x NA Tender / Call Premiums - - % Enterprise Value - Cash Return NM Term Loan C - - % - x - x NA Financing Fees - - % 2nd Lien - - % - x - x NA Other Fees and Expenses - - % Transaction Multiples Options Senior Notes - - % - x - x NA Enterprise Value / Sales Financing Structure 1 Senior Subordinated Notes - - % - x - x NA LTM 9/30/2008 - - x Operating Scenario 1 Equity Contribution - - % - x - x 2008E - - x Cash Flow Sweep 1 Rollover Equity - - % - x - x Enterprise Value / EBITDA Cash Balance 1 Cash on Hand - - % - x - x LTM 9/30/2008 - - x Average Interest 1 Total Sources - - % - x - x Total Uses - - % 2008E - - x Financing Fees 1 Projection Period LTM Pro forma Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10 2005 2006 2007 9/30/2008 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Sales - - - - - - - - - - - - - - % growth NA - - NA - - - - - - - - - - -Gross Profit - - - - - - - - - - - - - - % margin - - - - - - - - - - - - - - -EBITDA - - - - - - - - - - - - - - % margin - - - - - - - - - - - - - - -Capital Expenditures - - - % sales - - - - - - - - - - - - - - -Cash Interest Expense - - - -Total Interest Expense - - - -Free Cash Flow EBITDA - - - -Less: Cash Interest Expense - - - -Plus: Interest Income - - - -Less: Income Taxes - - - -Less: Capital Expenditures - - - -Less: Increase in Net Working Capital - - - Free Cash Flow - - - - - - - - - Cumulative Free Cash Flow - - - -Cash - - - -Revolving Credit Facility - - - -Term Loan A - - - -Term Loan B - - - -Term Loan C - - - -Existing Term Loan - - - -2nd Lien - - - -Other Debt - - - Total Senior Secured Debt - - - - - - - - - - -Senior Notes - - - Total Senior Debt - - - - - - - - - - -Senior Subordinated Notes - - - Total Debt - - - - - - - - - - -Shareholders' Equity - - - Total Capitalization - - - - - - - - - - % of Bank Debt Repaid - - - - - - - - - - -% Debt / Total Capitalization - - - - - - - - - - -EBITDA / Cash Interest Expense - x - x - x - x - x - x - x - x - x - x - x

(EBITDA - Capex) / Cash Interest Expense - x - x - x - x - x - x - x - x - x - x - x

EBITDA / Total Interest Expense - x - x - x - x - x - x - x - x - x - x - x

(EBITDA - Capex) / Total Interest Expense - x - x - x - x - x - x - x - x - x - x - x

Senior Secured Debt / EBITDA - x - x - x - x - x - x - x - x - x - x - x

Senior Debt / EBITDA - x - x - x - x - x - x - x - x - x - x - x

Total Debt / EBITDA - x - x - x - x - x - x - x - x - x - x - x Net Debt / EBITDA NM NM NM NM NM NM NM NM NM NM NM Transaction Summary

Historical Period

Capitalization

Credit Statistics Summary Financial Data

(3)

($ in millions, fiscal year ending December 31)

Historical Period Projection Period

LTM Pro forma Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2005 2006 2007 9/30/2008 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Sales - - - - - - - - - - - - - -

% growth NA - - NA - - - - - - - - - - -Cost of Goods Sold - - -

-Gross Profit - - - - - - - - - - - - - -

% margin - - - - - - - - - - - - - - -Selling, General & Administrative - - - % sales - - - - - - - - - - - - - - -Other Expense / (Income) - - -

-EBITDA - - - - - - - - - - - - - -

% margin - - - - - - - - - - - - - - -Depreciation & Amortization - - -

-EBIT - - - - - - - - - - - - - -

% margin - - - - - - - - - - - - - - -Interest Expense

Revolving Credit Facility - - -

-Term Loan A - - -

-Term Loan B - - -

-Term Loan C - - -

-Existing Term Loan - - -

-2nd Lien - - -

-Senior Notes - - -

-Senior Subordinated Notes - - -

-Commitment Fee on Unused Revolver - - -

-Administrative Agent Fee - - -

Cash Interest Expense - - - - - - - - - -

-Amortization of Deferred Financing Fees - - -

Total Interest Expense - - - - - - - - - -

-Interest Income - - -

Net Interest Expense - - - - - - - - - -Earnings Before Taxes - - -

-Income Tax Expense - - -

Net Income - - - - - - - - -

% margin - - - - - - - - - -Income Statement Assumptions

Sales (% YoY growth) NA - % - % NA - % - % - % - % - % - % - % - % - % - % - % Cost of Goods Sold (% margin) - % - % - % - % - % - % - % - % - % - % - % - % - % - % - % SG&A (% sales) - % - % - % - % - % - % - % - % - % - % - % - % - % - % - % Other Expense / (Income) (% of sales) - % - % - % - % - % - % - % - % - % - % - % - % - % - % - % Depreciation & Amortization (% of sales) - % - % - % - % - % - % - % - % - % - % - % - % - % - % - %

Interest Income - % - % - % - % - % - % - % - % - % - % - %

Tax Rate - % - % - % - % - % - % - % - % - % - %

(4)

($ in millions, fiscal year ending December 31)

Projection Period

Opening Adjustments Pro Forma Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2008 + - 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Cash and Cash Equivalents - - - -Accounts Receivable - - - -Inventories - - - -Prepaids and Other Current Assets - - - Total Current Assets - - - - - - - - - - - -Property, Plant and Equipment, net - - - -Goodwill and Intangible Assets - - - -Other Assets - - - -Deferred Financing Fees - - - Total Assets - - - - - - - - - - - -Accounts Payable - - - -Accrued Liabilities - - - -Other Current Liabilities - - - Total Current Liabilities - - - - - - - - - - - -Revolving Credit Facility - - - -Term Loan A - - - -Term Loan B - - - -Term Loan C - - - -Existing Term Loan - - - -2nd Lien - - - -Senior Notes - - - -Senior Subordinated Notes - - - -Other Debt - - - -Other Long-Term Liabilities - - - Total Liabilities - - - - - - - - - - - -Noncontrolling Interest - - - -Shareholders' Equity - - - Total Shareholders' Equity - - - - - - - - - - - Total Liabilities and Equity - - - - - - - - - - -

-Balance Check 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000

Net Working Capital - - - -(Increase) / Decrease in Net Working Capital - - -

-Balance Sheet Assumptions

Days Sales Outstanding (DSO) - - - -Days Inventory Held (DIH) - - - -Prepaid and Other Current Assets (% of sales) - % - % - % - % - % - % - % - % - % - % - % - %

Days Payable Outstanding (DPO) - - - -Accrued Liabilities (% of sales) - % - % - % - % - % - % - % - % - % - % - % - % Other Current Liabilities (% of sales) - % - % - % - % - % - % - % - % - % - % - % - % Balance Sheet

Current Assets

(5)

($ in millions, fiscal year ending December 31)

Projection Period

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Operating Activities

Net Income - - -

Plus: Depreciation & Amortization - - -

Plus: Amortization of Financing Fees - - -

Changes in Working Capital Items

(Inc.) / Dec. in Accounts Receivable - - -

(Inc.) / Dec. in Inventories - - -

(Inc.) / Dec. in Prepaid and Other Current Assets - - -

Inc. / (Dec.) in Accounts Payable - - -

Inc. / (Dec.) in Accrued Liabilities - - -

Inc. / (Dec.) in Other Current Liabilities - - -

(Inc.) / Dec. in Net Working Capital - - -

Cash Flow from Operating Activities - - - - - - - - -

-Investing Activities

Capital Expenditures - - -

Other Investing Activities - - -

Cash Flow from Investing Activities - - - - - - - - -

-Financing Activities

Revolving Credit Facility - - -

Term Loan A - - -

Term Loan B - - -

Term Loan C - - -

Existing Term Loan - - -

2nd Lien - - -

Senior Notes - - -

Senior Subordinated Notes - - -

Other Debt - - -

Dividends - - -

Equity Issuance / (Repurchase) - - -

Cash Flow from Financing Activities - - - - - - - - -

Excess Cash for the Period - - -

Beginning Cash Balance - - -

Ending Cash Balance - - - - - - - - -

-Cash Flow Statement Assumptions

Capital Expenditures (% of sales) - % - % - % - % - % - % - % - % - % - %

(6)

($ in millions, fiscal year ending December 31)

Projection Period

Pro forma Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Forward LIBOR Curve - % - % - % - % - % - % - % - % - % - % - %

Cash Flow from Operating Activities - - - -Cash Flow from Investing Activities - - - Cash Available for Debt Repayment - - - - - - - - - -Total Mandatory Repayments MinCash - - - -Cash From Balance Sheet - - - Cash Available for Optional Debt Repayment - - - - - - - - -

-Revolving Credit Facility

Revolving Credit Facility Size

-Spread - %

Term 0 years

Commitment Fee on Unused Portion - %

Beginning Balance - - - -Drawdown/(Repayment) - - - Ending Balance - - - - - - - - - -Interest Rate - - - - - - - - -

-Average Interest Expense - - - -Commitment Fee - - -

-Term Loan B Facility

Size

-Spread - %

Term 0 years

Repayment Schedule - % Per Annum, Bullet at Maturity

Beginning Balance - - - -Mandatory Repayments - - - -Optional Repayments - - - Ending Balance - - - - - - - - - -Interest Rate - - - - - - - - - -Interest Expense - - -

-Senior Subordinated Notes

Size -Coupon - % Term 0 years Beginning Balance - - - -Repayment - - - Ending Balance - - - - - - - - - -Interest Expense - - - -Debt Schedule

(7)

($ in millions, fiscal year ending December 31)

Projection Period

Pro forma Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Entry EBITDA Multiple - x

Initial Equity Investment

EBITDA - - - -Exit EBITDA Multiple - x

Enterprise Value at Exit - - - - - - - - - -Less: Net Debt

Revolving Credit Facility - - - -Term Loan A - - - -Term Loan B - - - -Term Loan C - - - -Existing Term Loan - - - -2nd Lien - - - -Senior Notes - - - -Senior Subordinated Notes - - - -Other Debt - - - Total Debt - - - - - - - - - -Less: Cash and Cash Equivalents - - - Net Debt - - - - - - - - - Equity Value at Exit - - - - - - - - -

-Cash Return NM NM NM NM NM NM NM NM NM NM

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Initial Equity Investment - - - -Equity Proceeds - - - - - - - - - - - - - - - - - - - - - - IRR NA NA NA NA NA NA NA NA NA NA

IRR - Assuming Exit in 2013E IRR - Assuming 0.0x Entry Multiple

Exit Multiple Exit Year

NA -1.0x -0.5x 0.0x 0.5x 1.0x -2 -1 0 1 2 -1.0x NA NA NA NA NA 6.5x NA NA NA NA NA Entry -0.5x NA NA NA NA NA Exit 7.0x NA NA NA NA NA Multiple 0.0x NA NA NA NA NA Multiple 7.5x NA NA NA NA NA 0.5x NA NA NA NA NA 8.0x NA NA NA NA NA 1.0x NA NA NA NA NA 8.5x NA NA NA NA NA Returns Analysis

(8)

Projection Period

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Income Statement Assumptions

Sales (% growth) - % - % - % - % - % - - - - Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - -

-Cost of Goods Sold (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - - -SG&A (% sales) - % - % - % - % - % - - - - Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - -

-Depreciation & Amortization (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - - -Interest Income - % - % - % - % - % - - - - Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - -

-Cash Flow Statement Assumptions

Capital Expenditures (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - -

Sponsor 2 - % - % - % - % - % - - - -

Management 3 - % - % - % - % - % - - - -

Downside 1 4 - % - % - % - % - % - - - -

Downside 2 5 - % - % - % - % - % - - - -

(9)

Projection Period

Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Current Assets

Days Sales Outstanding (DSO) - - -

Base 1 - - -

Sponsor 2 - - -

Management 3 - - -

Downside 1 4 - - -

Downside 2 5 - - -

-Days Inventory Held (DIH) - - -

Base 1 - - -

Sponsor 2 - - -

Management 3 - - -

Downside 1 4 - - -

Downside 2 5 - - -

-Prepaids and Other Current Assets (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - - Sponsor 2 - % - % - % - % - % - - - - Management 3 - % - % - % - % - % - - - - Downside 1 4 - % - % - % - % - % - - - - Downside 2 5 - % - % - % - % - % - - - - -Current Liabilities

Days Payable Outstanding (DPO) - - -

Base 1 - - -

Sponsor 2 - - -

Management 3 - - -

Downside 1 4 - - -

Downside 2 5 - - -

-Accrued Liabilities (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - -

Sponsor 2 - % - % - % - % - % - - - -

Management 3 - % - % - % - % - % - - - -

Downside 1 4 - % - % - % - % - % - - - -

Downside 2 5 - % - % - % - % - % - - - -

-Other Current Liabilities (% sales) - % - % - % - % - % - - - -

Base 1 - % - % - % - % - % - - - -

Sponsor 2 - % - % - % - % - % - - - -

Management 3 - % - % - % - % - % - - - -

Downside 1 4 - % - % - % - % - % - - - -

Downside 2 5 - % - % - % - % - % - - - -

(10)

($ in millions)

Structure Public / Private Target 2

1 2 3 4 5

Structure 1 Structure 2 Structure 3 Structure 4 Status Quo Entry EBITDA Multiple - x Revolving Credit Facility Size - - - - - LTM 9/30/2008 EBITDA -Revolving Credit Facility Draw - - - - - Enterprise Value -Term Loan A - - - -

-Term Loan B - - - - - Less: Total Debt -Term Loan C - - - - - Less: Preferred Securities

-2nd Lien - - - - - Less: Noncontrolling Interest -Senior Notes - - - - - Plus: Cash and Cash Equivalents -Senior Subordinated Notes - - - - - Equity Purchase Price -Equity Contribution - - - -

-Rollover Equity - - - -

-Cash on Hand - - - -

- - - - Offer Price per Share

Total Sources of Funds - - - -

-Basic Shares Outstanding

-Plus: Shares from In-the-Money Options -Equity Purchase Price - - - - - Less: Shares Repurchased -Repay Existing Bank Debt - - - - - Net New Shares from Options -Tender / Call Premiums - - - - - Plus: Shares from Convertible Securities -Financing Fees - - - - - Fully Diluted Shares Outstanding -Other Fees and Expenses - - - -

- - -

- - -

- - - - Number of Exercise In-the-Money

- - - - Tranche Shares Price Shares Proceeds Total Uses of Funds - - - - - Tranche 1 - - -

-Tranche 2 - - - -Tranche 3 - - - -Tranche 4 - - - -Structure 1 Size (%) ($) Tranche 5 - - - -Revolving Credit Facility Size - - - Total - - -Term Loan A - -

-Term Loan B - -

-Term Loan C - - - Conversion Conversion New 2nd Lien - - - Amount Price Ratio Shares Senior Notes - - - Issue 1 - - - -Senior Subordinated Notes - - - Issue 2 - - - -Senior Bridge Facility - - - Issue 3 - - - -Senior Subordinated Bridge Facility - - - Issue 4 - - - -Other Financing Fees & Expenses - Issue 5 - - -

Total Financing Fees - Total

-Year 1 Year 2 Year 3 Year 4 Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

Term 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018

Revolving Credit Facility Size - - - -Term Loan A - - - -Term Loan B - - - -Term Loan C - - - -2nd Lien - - - -Senior Notes - - - -Senior Subordinated Notes - - - -Senior Bridge Facility - - - -Senior Subordinated Bridge Facility - - - -Other Financing Fees & Expenses - - - Annual Amortization - - - - - - - - - Administrative Agent Fee - - - - - - - - -

-Amortization of Financing Fees Financing Fees

Convertible Securities Fees

Assumptions Page 3 - Financing Structures and Fees

Options/Warrants

Purchase Price

Calculation of Fully Diluted Shares Outstanding

Sources of Funds

Uses of Funds

(11)

Copyright © 2009 by Joshua Rosenbaum and Joshua Pearl. All rights reserved. Published by John Wiley & Sons, Inc., Hoboken, New Jersey.

Published simultaneously in Canada.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permissions. Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.

For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.

Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. For more information about Wiley products, visit our web site at www.wiley.com.

Library of Congress Cataloging-in-Publication Data:

ISBN-13 978-0-470-44220-3

Printed in the United States of America 10 9 8 7 6 5 4 3 2 1

References

Related documents

These findings are discussed further below in relation to the spatial distribution of endemic areas, the quality of predictive intermediate host traits (particularly genetic

They don’t have a positive expectation that something good is going to happen to them because of God’s great goodness.. I believe hope precedes and is connected

“I think the college experience shapes people in so many ways, and I think it’s important that people know a little bit at least about the school that they attend outside of

In this context, the main goal of this study was to investigate the phytochemical composition (flavonoids and carotenoids) and antioxidant capacity of taxo and,

Tuition and fee information can be found in “Tuition and Fees” section of the catalog. Modular programs are offered throughout the year on a schedule independent of the

Delaware Department of Education, CACFP Procurement Page: https://www.doe.k12.de.us/Page/2788 Delaware Department of Education, SNP Procurement Page:

In comparison with the cumulative successful rates of maxillary and mandibular implants in Buser et al.’s (1997), respectively, 87.2% and 95.6%, the cumulative successful rate

significantly greater intention to smoke than their White counterparts, (RQ10) there was a significant difference among the ethnic groups on the number of days they smoked a